| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 45.208 | 50.501 | 58.291 | 0 | 5.608 | 35.654 | 1.971 | 3.135 | 2.132 |
| Total Income - EUR | - | 45.208 | 50.513 | 58.291 | 0 | 5.608 | 38.591 | 2.553 | 3.135 | 2.132 |
| Total Expenses - EUR | - | 20.943 | 36.727 | 67.079 | 1.015 | 3.869 | 21.036 | 8.463 | 11.162 | 7.820 |
| Gross Profit/Loss - EUR | - | 24.265 | 13.786 | -8.789 | -1.015 | 1.739 | 17.555 | -5.910 | -8.028 | -5.688 |
| Net Profit/Loss - EUR | - | 23.193 | 13.279 | -9.372 | -1.015 | 1.586 | 17.423 | -5.950 | -8.059 | -5.688 |
| Employees | - | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Bellamed Grup Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 9.798 | 8.629 | 7.718 | 7.568 | 5.659 | 1.326 | 2.391 | 1.841 | 1.653 |
| Current Assets | - | 23.058 | 29.453 | 18.854 | 2.391 | 5.574 | 27.813 | 16.297 | 9.650 | 2.943 |
| Inventories | - | 1.174 | 6.387 | 2.159 | 2.117 | 870 | 1.811 | 3.779 | 2.854 | 2.461 |
| Receivables | - | 7.148 | 4.163 | 0 | 0 | 68 | 125 | 44 | 0 | 0 |
| Cash | - | 14.736 | 18.902 | 16.695 | 274 | 4.636 | 25.876 | 12.473 | 6.796 | 482 |
| Shareholders Funds | - | 23.238 | 36.124 | 26.089 | 9.818 | 11.217 | 28.391 | 18.652 | 10.536 | 4.790 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 9.619 | 1.958 | 503 | 142 | 17 | 937 | 210 | 1.117 | 0 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "1423 - 1423" | |||||||||
| CAEN Financial Year |
1412
|
|||||||||
Comments - Bellamed Grup Srl